SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study

NCT07198191 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

200000

Enrollment

OTHER

Sponsor class

Conditions

Acute Myocardial Infarction (AMI)
Type 2 Diabetes Mellitus (T2DM)

Interventions

DRUG: SGLT2 inhibitors (e.g., dapagliflozin, empagliflozin)
DRUG: DPP4 inhibitors

Sponsor

Yonsei University

Collaborators

[object Object]
[object Object]